DocGo Inc. Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount
DocGo Inc. (DCGO) reported Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount of $5.00 million for the 3-month period ending 2025-12-31, per its 10-Q filed 2026-08-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount · last filed 2026-08-17
- DocGo Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2025-12-31 was $5.00M.
- DocGo Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2025-09-30 was $0.00.
- DocGo Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2025-06-30 was $0.00.
- DocGo Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2025-03-31 was $0.00.
- DocGo Inc. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2024 was $0.00.
- DocGo Inc. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2023 was $0.00.
- DocGo Inc. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2022 was $0.00.
| Period end | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 3 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 6 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 9 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 12 month |
|---|---|---|---|---|
| 2025-12-31 | $5.00M 10-Q · filed 2026-08-17 | $5.00M derived: sum of 2 quarters · filed 2026-08-17 | $5.00M derived: sum of 3 quarters · filed 2026-08-17 | $5.00M 10-Q · filed 2026-08-17 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2025-11-10 | $0.00 10-Q · filed 2025-11-10 | $0.00 derived: sum of 4 quarters · filed 2026-03-16 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-03-16 | $0.00 derived: sum of 4 quarters · filed 2026-03-16 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-03-16 | $0.00 derived: sum of 3 quarters · filed 2026-03-16 | $0.00 derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $0.00 derived: sum of 2 quarters · filed 2026-03-16 | $0.00 derived: sum of 3 quarters · filed 2026-03-16 | $0.00 10-K · filed 2026-03-16 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2025-11-10 | $0.00 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-03-16 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |